ArticleCancer science2024

CCL5/CCR5/CYP1A1 pathway prompts liver cancer cells to survive in the combination of targeted and immunological therapies.

Yafei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.